Table of Contents
Chapter 1.Executive Summary
1.1.Market Snapshot
1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1.Atrial Fibrillation Market, by Region, 2020-2030 (USD Billion)
1.2.2.Atrial Fibrillation Market, by Treatment Type, 2020-2030 (USD Billion)
1.2.3.Atrial Fibrillation Market, by End-use, 2020-2030 (USD Billion)
1.3.Key Trends
1.4.Estimation Methodology
1.5.Research Assumption
Chapter 2.Global Atrial Fibrillation Market Definition and Scope
2.1.Objective of the Study
2.2.Market Definition & Scope
2.2.1.Industry Evolution
2.2.2.Scope of the Study
2.3.Years Considered for the Study
2.4.Currency Conversion Rates
Chapter 3.Global Atrial Fibrillation Market Dynamics
3.1.Atrial Fibrillation Market Impact Analysis (2020-2030)
3.1.1.Market Drivers
3.1.1.1.Increasing government initiatives and healthcare reforms
3.1.1.2.Rising inclination towards minimally invasive procedures for AFib treatment
3.1.2.Market Challenges
3.1.2.1.High costs associated with AFib procedures and devices
3.1.2.2.Regulatory issues associated with the devices
3.1.3.Market Opportunities
3.1.3.1.Increasing research and development activities
3.1.3.2.Growing number of programs to enhance public awareness
Chapter 4.Global Atrial Fibrillation Market Industry Analysis
4.1.Porter's 5 Force Model
4.1.1.Bargaining Power of Suppliers
4.1.2.Bargaining Power of Buyers
4.1.3.Threat of New Entrants
4.1.4.Threat of Substitutes
4.1.5.Competitive Rivalry
4.2.Porter's 5 Force Impact Analysis
4.3.PEST Analysis
4.3.1.Political
4.3.2.Economical
4.3.3.Social
4.3.4.Technological
4.3.5.Environmental
4.3.6.Legal
4.4.Top investment opportunity
4.5.Top winning strategies
4.6.COVID-19 Impact Analysis
4.7.Disruptive Trends
4.8.Industry Expert Perspective
4.9.Analyst Recommendation & Conclusion
Chapter 5.Global Atrial Fibrillation Market, by Treatment Type
5.1.Market Snapshot
5.2.Global Atrial Fibrillation Market by Treatment Type, Performance - Potential Analysis
5.3.Global Atrial Fibrillation Market Estimates & Forecasts by Treatment Type 2020-2030 (USD Billion)
5.4.Atrial Fibrillation Market, Sub Segment Analysis
5.4.1.Pharmacological Treatment
5.4.2.Non-Pharmacological Treatment
Chapter 6.Global Atrial Fibrillation Market, by End-use
6.1.Market Snapshot
6.2.Global Atrial Fibrillation Market by End-use, Performance - Potential Analysis
6.3.Global Atrial Fibrillation Market Estimates & Forecasts by End-use 2020-2030 (USD Billion)
6.4.Atrial Fibrillation Market, Sub Segment Analysis
6.4.1.Hospitals
6.4.2.Specialty Clinics
6.4.3.Others
Chapter 7.Global Atrial Fibrillation Market, Regional Analysis
7.1.Top Leading Countries
7.2.Top Emerging Countries
7.3.Atrial Fibrillation Market, Regional Market Snapshot
7.4.North America Atrial Fibrillation Market
7.4.1.U.S. Atrial Fibrillation Market
7.4.1.1.Treatment Type breakdown estimates & forecasts, 2020-2030
7.4.1.2.End-use breakdown estimates & forecasts, 2020-2030
7.4.2.Canada Atrial Fibrillation Market
7.5.Europe Atrial Fibrillation Market Snapshot
7.5.1.U.K. Atrial Fibrillation Market
7.5.2.Germany Atrial Fibrillation Market
7.5.3.France Atrial Fibrillation Market
7.5.4.Spain Atrial Fibrillation Market
7.5.5.Italy Atrial Fibrillation Market
7.5.6.Rest of Europe Atrial Fibrillation Market
7.6.Asia-Pacific Atrial Fibrillation Market Snapshot
7.6.1.China Atrial Fibrillation Market
7.6.2.India Atrial Fibrillation Market
7.6.3.Japan Atrial Fibrillation Market
7.6.4.Australia Atrial Fibrillation Market
7.6.5.South Korea Atrial Fibrillation Market
7.6.6.Rest of Asia Pacific Atrial Fibrillation Market
7.7.Latin America Atrial Fibrillation Market Snapshot
7.7.1.Brazil Atrial Fibrillation Market
7.7.2.Mexico Atrial Fibrillation Market
7.8.Middle East & Africa Atrial Fibrillation Market
7.8.1.Saudi Arabia Atrial Fibrillation Market
7.8.2.South Africa Atrial Fibrillation Market
7.8.3.Rest of Middle East & Africa Atrial Fibrillation Market
Chapter 8.Competitive Intelligence
8.1.Key Company SWOT Analysis
8.2.Top Market Strategies
8.3.Company Profiles
8.3.1. Boston Scientific Corporation
8.3.1.1.Key Information
8.3.1.2.Overview
8.3.1.3.Financial (Subject to Data Availability)
8.3.1.4.Product Summary
8.3.1.5.Recent Developments
8.3.2.Medtronic PLC
8.3.3.Biotronik SE & Co. KG
8.3.4.AtriCure Inc.
8.3.5.Cardiofocus Inc.
8.3.6.Abbott Laboratories
8.3.7.Johnson & Johnson
8.3.8.MicroPort Scientific Corporation
8.3.9.Koninklijke Philips NV
8.3.10.Siemens AG
Chapter 9.Research Process
9.1.Research Process
9.1.1.Data Mining
9.1.2.Analysis
9.1.3.Market Estimation
9.1.4.Validation
9.1.5.Publishing
9.2.Research Attributes
9.3.Research Assumption